Title : BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.

Pub. Date : 2018 Dec

PMID : 30155839






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 METHODS: The synergistic effect of gemcitabine combined with specific B cell CLL/lymphoma 2 (Bcl-2) inhibitor ABT-199 against pancreatic cancer was tested using cell viability, cell cycle, and apoptosis assays in vitro and in an MIA Paca-2 xenograft model in vivo. venetoclax B cell leukemia/lymphoma 2 Mus musculus
2 METHODS: The synergistic effect of gemcitabine combined with specific B cell CLL/lymphoma 2 (Bcl-2) inhibitor ABT-199 against pancreatic cancer was tested using cell viability, cell cycle, and apoptosis assays in vitro and in an MIA Paca-2 xenograft model in vivo. venetoclax B cell leukemia/lymphoma 2 Mus musculus